EUVIMEDEUVIMED entdecken
Crossref

Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors

Ming Wang, Qiuyuan Deng, Wei Zhang, Qing Qi

Biochemical and Biophysical Research Communications · 2024

DOI: 10.1016/j.bbrc.2024.150653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Ming Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Flavanones, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Fusion Proteins, bcr-abl, Protein Kinase Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Health and Family Planning Commission of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic myeloid leukemia (CML) treatment with Bcr-Abl tyrosine kinase inhibitors (TKIs) has significantly improved patient outcomes, yet challenges such as drug resistance and persistence of leukemic stem cells persist. This study explores the potential of naringenin, a natural flavonoid, to enhance the efficacy of Bcr-Abl TKIs in CML therapy. We showed that naringenin reduces viability of a panel of CML cell lines regardless of varying cellular origin and genetic mutations, and acts synergistically with dasatinib and ponatinib. Importantly, naringenin is effective in targeting blast crisis CML CD34+ cells by decreasing their colony formation, self-renewal and viability. Compared to CML, naringenin is significantly less effective against normal bone marrow (NBM) counterparts. In addition, naringenin significantly enhances the inhibitory effects of dasatinib in CML but not NBM CD34+ cells. Mechanism studies showed that naringenin's inhibitory effects were associated with the induction of oxidative stress and lipid damage, as evidenced by increased reactive oxygen species (ROS) and malondialdehyde (MDA) levels. Notably, naringenin upregulated genes related to mitochondrial biogenesis while downregulating antioxidant defense genes. Pretreatment with α-tocopherol, which inhibits lipid-mediated ROS production, completely abolished the ROS increase and restored cell viability, indicating that lysosomal lipid peroxidation plays a crucial role in naringenin's mechanism of action. In a CML xenograft mouse model, the combination of naringenin and dasatinib resulted in remarkably more tumor growth suppression compared to single drug alone. Importantly, this combination was well-tolerated, with no adverse effects on body weight observed. These findings suggest that naringenin, by inducing oxidative lipid damage, enhances the anti-leukemic effects of Bcr-Abl TKIs, offering a promising therapeutic strategy for CML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveFusion Proteins, bcr-ablProtein Kinase InhibitorsOxidative StressHumansAnimalsCell Line, TumorMiceDasatinibDrug SynergismReactive Oxygen SpeciesPyridazinesXenograft Model Antitumor AssaysCell SurvivalImidazolesAntineoplastic AgentsTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

Bcr-Abl TKIsCMLNaringeninOxidative lipid damageSynergy

Substanzen

FlavanonesnaringeninFusion Proteins, bcr-ablProtein Kinase InhibitorsDasatinibponatinibReactive Oxygen SpeciesPyridazinesImidazolesAntineoplastic Agents

Autor:innen und Institutionen

  • Geriatric Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China.
  • Department of General Medicine, Hospital of Huazhong Agricultural University, Wuhan, Hubei, China.
  • Public Health Division, Hospital of Huazhong Agricultural University, Wuhan, Hubei, China.
  • Wuhan Business University, Wuhan, Hubei, China. Electronic address: logi_2024@163.com.

Förderung

  • Health and Family Planning Commission of Hubei Province

Zitieren

APA

Wang, M., Deng, Q., Zhang, W., & Qi, Q. (2024). Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150653

Vancouver

Wang M, Deng Q, Zhang W, Qi Q. Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150653

BibTeX
@article{Wang2024,
  author = {Wang, Ming and Deng, Qiuyuan and Zhang, Wei and Qi, Qing},
  title = {Oxidative lipid damage by naringenin selectively sensitizes chronic myeloid leukemia cell lines and patient samples to Bcr-Abl tyrosine kinase inhibitors},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2024},
  doi = {10.1016/j.bbrc.2024.150653}
}
Kostenlos starten →